Santos, Elizeu Antunes dosSerquiz, Raphael Paschoal2018-07-092018-07-092017-10-25SERQUIZ, Raphael Paschoal. Inibidor de serinoproteinase obtido de sementes de Juquiri (Mimosa regnelli Benth.) com atividade anti-inflamatória, anticoagulante e adjuvante da heparina. 2017. 95f. Dissertação (Mestrado em Bioquímica) - Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, 2017.https://repositorio.ufrn.br/jspui/handle/123456789/25528Hemostasis is the event that mammals use to block the loss of blood and promote injury repair, and failure by overeating contributes to the spread of inflammatory and thrombotic factors. Atherosclerosis is an example of such diseases, and heparin (Hep) is a treatment drug. Patients with antithrombin deficiency have resistance to the anticoagulant effects of Hep, so researches for novel homeostatic molecules that contribute to clinical treatments are necessary. Plant protease inhibitors have been effective in controlling biological processes, such as coagulation and inflammation. The present work aimed isolate a trypsin inhibitor from the Juquiri (JTI) seed and evaluate its activity against serine proteases, and its anticoagulant and antiinflammatory potentials. JTI was isolated by affinity and ion exchange chromatography, presenting two major protein bands of 11.9 and 19.2 kDa on SDSPAGE, and was able to inhibit trypsin and chymotrypsin. In coagulation, JTI prolonged partial thromboplastin time (APTT) at concentrations greater than 2 μg/100 μL plasma, without prolonging prothrombin time (PT). Associated with Hep, JTI was able to enhance the anticoagulant effect of the drug in both tests. Without toxicity to human erythrocytes, JTI reduced 40% of elastase concentrations released by neutrophils induced by platelet activating factor (PAF). JTI at concentrations between 20-80 μg/mL stimulated TNF production by macrophages (RAW 264.7) in culture without provoking other inflammatory stimuli. LPS-activated macrophages had a reduction in NO, IL-6 and TNF productions when treated with JTI at 20-160 μg/mL concentrations. These data point to JTI as promising in the treatment of thrombotic and inflammatory diseases and have been effective as heparin adjuvant and to promote the reduction of neutrophil inflammatory stimuli likely by MAPK-dependent pathways and in macrophages by NF-κB transcription factor pathways.Acesso AbertoTromboseNeutrófiloMacrófagoTripsinaQuimotripsinaElastasmasterThesisCNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA